EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Morbidity and Mortality of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: National Cancer Institute, Mexico City, Mexico

Horacio N López-Basave, Flavia Morales-Vásquez, J M Ruiz Molina, Aaron González-Enciso, Silvio A Namendys-Silva, Juan M Medina Castro, Gonzalo Montalvo-Esquivel, Angel Herrera-Gómez, Jaime G De la Garza Salazar

ISRN Oncology · 2011

DOI: 10.5402/2011/526384 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ISRN Oncology, 2011. Verfasst von Horacio N López-Basave und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, National Cancer Institute, San Fernando No. 22 Colonia Seccion XVI, Tlalpan, 14080 Mexico City, DF, Mexico. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peritoneal carcinomatosis (PC) is generally considered a lethal disease, with a poor prognosis. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has emerged as a new approach for peritoneal surface disease. This study investigated the early experience with this combined modality treatment at a single institute. From January 2007 to March 2010, 24 patients were treated After aggressive CS, with HIPEC (cisplatin 25 mg/m 2 /L and mitomycin C 3.3 mg/m 2 /L was administered for 90-minutes at 40.5° C). These data suggest that aggressive CRS with HIPEC for the treatment of PC may result in low mortality and acceptable morbidity. Rigorous patient selection, appropriate and prudent operative procedures were associated with encouraging results in our experience.

Autor:innen und Institutionen

  • Department of Surgical Oncology, National Cancer Institute, San Fernando No. 22 Colonia Seccion XVI, Tlalpan, 14080 Mexico City, DF, Mexico.

Zitieren

APA

López-Basave, H. N., Morales-Vásquez, F., Ruiz Molina, J. M., González-Enciso, A., Namendys-Silva, S. A., Medina Castro, J. M., Montalvo-Esquivel, G., Herrera-Gómez, A., & De la Garza Salazar, J. G. (2011). Morbidity and Mortality of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: National Cancer Institute, Mexico City, Mexico. ISRN Oncology. https://doi.org/10.5402/2011/526384

Vancouver

López-Basave HN, Morales-Vásquez F, Ruiz Molina JM, González-Enciso A, Namendys-Silva SA, Medina Castro JM, et al. Morbidity and Mortality of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: National Cancer Institute, Mexico City, Mexico. ISRN Oncology. 2011. doi:10.5402/2011/526384

BibTeX
@article{LpezBasave2011,
  author = {López-Basave, Horacio N and Morales-Vásquez, Flavia and Ruiz Molina, J M and González-Enciso, Aaron and Namendys-Silva, Silvio A and Medina Castro, Juan M and Montalvo-Esquivel, Gonzalo and Herrera-Gómez, Angel and De la Garza Salazar, Jaime G},
  title = {Morbidity and Mortality of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: National Cancer Institute, Mexico City, Mexico},
  journal = {ISRN Oncology},
  year = {2011},
  doi = {10.5402/2011/526384}
}
Kostenlos starten →